MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11695-026-08505-8

Медицинская библиотека · Obesity surgery · 2026

Endoscopic Sleeve Gastroplasty: 6-Year Outcomes in 1,377 Patients.

Neto Manoel Galvao, Bhandari Mohit, Reddy Manoj, Bhandari Mahak, Ranganath Sonika, Kosta Susmit, Mathur Winni

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Endoscopic sleeve gastroplasty (ESG) is a minimally invasive endoluminal bariatric procedure, but long-term outcomes beyond 5 years remain limited. This study reports 6-year weight loss, comorbidity outcomes, and safety data from a large single-center cohort.

METHODS

This retrospective cohort study included adults undergoing ESG between June 2019 and June 2025 with mean follow up of 3.8 ± 1.4 years. Primary outcomes were percent total weight loss (%TWL) and percent excess weight loss (%EWL) assessed up to 6 years. Secondary outcomes included resolution or improvement of type 2 diabetes mellitus (T2DM), hypertension, obstructive sleep apnea (OSA), and dyslipidemia. Adverse events and revision procedures were recorded. Missing data were handled using multiple imputation by chained equations within an intention-to-treat framework, with sensitivity analyses using non-responder imputation and last-observation-carried-forward methods.

RESULTS

A total of 1,377 patients underwent ESG (mean age 41.5 ± 12.2 years; 53.5% female; baseline BMI 35.2 ± 4.8 kg/m²). Mean %TWL was 21.2% (95% CI 20.8–21.6) at 1 year and 14.4% (95% CI 14.0–14.8) at 6 years. Mean %EWL was 56.9% at 1 year and 43.4% at 6 years. At 6 years, resolution or improvement was observed in T2DM (51.2%), hypertension (65.8%), OSA (89.9%), and dyslipidemia (73.6%). There was no mortality. One patient (0.07%) required operative intervention for bleeding. Revision procedures occurred in 5.7% of patients.

CONCLUSIONS

This study shows that ESG produces measurable weight loss and achieves comorbidity improvement through 6 years, with a favourable safety profile and low revision rate. however, prospective comparative studies are needed to define its role relative to surgical and pharmacologic therapies.

Для цитирования: Neto Manoel Galvao, Bhandari Mohit, Reddy Manoj, Bhandari Mahak, Ranganath Sonika, Kosta Susmit, Mathur Winni. Endoscopic Sleeve Gastroplasty: 6-Year Outcomes in 1,377 Patients.. Obesity surgery. 2026. DOI: 10.1007/s11695-026-08505-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.